Skip to main content
PMC home page
Gut logoLink to Gut
. 1972 May;13(5):366–371. doi: 10.1136/gut.13.5.366

Effect of rifampicin on liver function in man

Philippe Capelle, Daniel Dhumeaux, Michel Mora, Gérard Feldmann, Pierre Berthelot
PMCID: PMC1412215  PMID: 5036092

Abstract

Liver function and serum concentrations of rifampicin, a highly cholephilic antibiotic, have been studied after ingestion of a single dose of 600 mg of rifampicin in 12 patients, six of them having a normal liver and six a cirrhotic, and during treatment with 600 mg of rifampicin per day for 17 days in eight patients, four of them having a normal liver and four a cirrhotic. Rifampicin produced competition for the elimination of bilirubin and bromsulphalein by the liver. This competition, which seemed to involve mainly the uptake by the liver cell, was always rapidly reversible when treatment was discontinued. It makes it impossible, however, to interpret a bromsulphalein test during treatment with rifampicin. In the eight patients treated for 17 days, apart from the competition already mentioned, no clinical, biological, or morphological abnormalities of the liver were ascertained. But in this limited number of patients it is not possible to exclude the fact that rifampicin could provoke jaundice by idiosyncrasy in a small percentage of cases. The serum concentrations of rifampicin were higher in cirrhotic patients than in patients with normal livers, especially after one or two weeks of treatment. It is suggested that efficient blood concentrations of rifampicin would be achieved with small doses in case of previous hepatocellular insufficiency.

Full text

PDF
370

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acocella G., Billing B. H. The effect of rifamycin SV on pigment excretion in rats. Gastroenterology. 1965 Nov;49(5):526–530. [PubMed] [Google Scholar]
  2. Acocella G., Mattiussi R., Nicolis F. B., Pallanza R., Tenconi L. T. Biliary excretion of antibiotics in man. Gut. 1968 Oct;9(5):536–545. doi: 10.1136/gut.9.5.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Acocella G., Nicolis F. B., Tenconi L. T. The effect of an intravenous infusion of rifamycin SV on the excretion of bilirubin, bromsulphalein, and indocyanine green in man. Gastroenterology. 1965 Nov;49(5):521–525. [PubMed] [Google Scholar]
  4. BOLT R. J., DILLON R. S., POLLARD H. M. Interference with bilirubin excretion by a gall-bladder dye (bunamiodyl). N Engl J Med. 1961 Nov 23;265:1043–1045. doi: 10.1056/NEJM196111232652105. [DOI] [PubMed] [Google Scholar]
  5. Berthelot P., Billing B. H. Effect of bunamiodyl on hepatic uptake of sulfobromophthalein in the rat. Am J Physiol. 1966 Aug;211(2):395–399. doi: 10.1152/ajplegacy.1966.211.2.395. [DOI] [PubMed] [Google Scholar]
  6. Constans P., Saint-Paul M., Morin Y., Bonnaud G., Bariety M. Etude des taux plasmatiques de rifampicine et de leurs variations (440 dosages) Acta Tuberc Pneumol Belg. 1969;60(3):299–314. [PubMed] [Google Scholar]
  7. Erlinger S., Emond M., Berthelot P., Benhamou J. P., Fauvert R. Effets de la novobiocine sur le fonctionnement du foie. II. Etude expérimentale. Rev Fr Etud Clin Biol. 1966 Aug-Sep;11(7):680–686. [PubMed] [Google Scholar]
  8. Furesz S. Recent investigations on the biological properties of rifampicin. Acta Tuberc Pneumol Belg. 1969;60(3):266–269. [PubMed] [Google Scholar]
  9. Lees A. W., Asgher B., Hashem M. A., Sinha B. N. Jaundice after rifampicin. Br J Dis Chest. 1970 Apr;64(2):90–95. doi: 10.1016/s0007-0971(70)80034-1. [DOI] [PubMed] [Google Scholar]
  10. Lesobre R., Ruffino J., Teyssier L., Achard F., Brefort G. Les ictères au cours du traitement par la rifampicine (12 observations) Rev Tuberc Pneumol (Paris) 1969 Apr-May;33(3):393–403. [PubMed] [Google Scholar]
  11. Levi A. J., Gatmaitan Z., Arias I. M. Two hepatic cytoplasmic protein fractions, Y and Z, and their possible role in the hepatic uptake of bilirubin, sulfobromophthalein, and other anions. J Clin Invest. 1969 Nov;48(11):2156–2167. doi: 10.1172/JCI106182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. NOSSLIN B. Bromsulphalein retention and jaundice due to unconjugated bilirubin following treatment with male fern extract. Scand J Clin Lab Invest. 1963;15 (Suppl 69):206–212. [PubMed] [Google Scholar]
  13. NOSSLIN B., MORGAN E. H. THE EFFECT OF PHLOROGLUCINOL DERIVATIVES FROM MALE FERN ON DYE EXCRETION BY THE LIVER IN THE RABBIT AND RAT. J Lab Clin Med. 1965 Jun;65:891–902. [PubMed] [Google Scholar]
  14. Vall-Spinosa A., Lester W., Moulding T., Davidson P. T., McClatchy J. K. Rifampin in the treatment of drug-resistant mycobacterium tuberculosis infections. N Engl J Med. 1970 Sep 17;283(12):616–621. doi: 10.1056/NEJM197009172831202. [DOI] [PubMed] [Google Scholar]
  15. Verbist L. Rifampicin blood levels in man. Acta Tuberc Pneumol Belg. 1969;60(3):288–298. [PubMed] [Google Scholar]
  16. WEBER A. P., SCHALM L. Quantitative separation and determination of bilirubin and conjugated bilirubin in human serum. Clin Chim Acta. 1962 Nov;7:805–810. doi: 10.1016/0009-8981(62)90063-3. [DOI] [PubMed] [Google Scholar]
  17. Zimmerman H. J. Papaverine revisited as a hepatotoxin. N Engl J Med. 1969 Dec 11;281(24):1364–1365. doi: 10.1056/NEJM196912112812413. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES